|
RASSF3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.030800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.823000E-01 |
| Normal-vs-Stage2 |
6.013800E-01 |
| Normal-vs-Stage3 |
4.065600E-01 |
| Normal-vs-Stage4 |
2.999800E-01 |
| Stage1-vs-Stage2 |
3.940400E-01 |
| Stage1-vs-Stage3 |
3.158600E-01 |
| Stage1-vs-Stage4 |
2.340000E-01 |
| Stage2-vs-Stage3 |
2.048000E-01 |
| Stage2-vs-Stage4 |
1.493610E-01 |
| Stage3-vs-Stage4 |
6.867400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.055800E-01 |
| Normal-vs-AfricanAmerican |
9.275800E-01 |
| Normal-vs-Asian |
7.152800E-01 |
| Caucasian-vs-AfricanAmerican |
7.778800E-01 |
| Caucasian-vs-Asian |
8.035400E-01 |
| AfricanAmerican-vs-Asian |
6.959400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.446000E-01 |
| Normal-vs-Female |
7.493800E-01 |
| Male-vs-Female |
7.343200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.550000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.695600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.384800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.449400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.521700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.168000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.606200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.406600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.647800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.457200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.169350E-01 |
| Classical-VS-Follicular |
2.203400E-01 |
| Classical-VS-Other |
6.486200E-02 |
| Classical-VS-Normal |
8.200400E-01 |
| Tall-VS-Follicular |
4.971600E-01 |
| Tall-VS-Other |
2.279200E-01 |
| Tall-VS-Normal |
2.363600E-01 |
| Follicular-VS-Other |
1.791440E-01 |
| Follicular-VS-Normal |
5.292600E-01 |
| Other-VS-Normal |
9.752400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.549000E-01 |
| Normal-vs-N1 |
1.749970E-01 |
| N0-vs-N1 |
1.907360E-01 |
|
|
